Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals; Drug: ADVAIR DISKUS® 500/50 Sponsors: Respirent Pharmaceuticals Co Ltd.; Becro Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials